Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Future Microbiol ; 16: 399-407, 2021 04.
Article in English | MEDLINE | ID: mdl-33847143

ABSTRACT

Background: Tuberculosis (TB) unevenly affects individuals across the globe, especially in rural areas of low-income countries. Aim of the study was to assess the impact of social protection to increase TB awareness on treatment outcomes among TB patients in a rural area of Senegal. Materials & methods: The study, conducted in Fimela district (Senegal) from 1 January 2010 to 31 December 2019 and the intervention started from 31 January 2013, includes activities to increase awareness, active case finding, active follow-up and social protection. Results: Overall, 435 subjects - mainly male and young - were included in the analysis. Among TB cases, 94% had pulmonary involvement, 87% had no previous TB history, and 6% resulted positive HIV. Improved outcome was observed once intervention began (from 71 to 91%, p < 0.001); whereas mortality decreased (from 15 to 5%; p < 0.001), especially for those HIV co-infected for whom TB mortality rate dropped from 70 to 29%. Conclusion: After beginning the cooperation program, TB treatment success increased as a result of the decline of mortality, especially in people living with HIV.


Subject(s)
Rural Population , Tuberculosis/drug therapy , Adult , Antitubercular Agents/therapeutic use , Coinfection/diagnosis , Coinfection/drug therapy , Coinfection/epidemiology , Female , HIV Infections/diagnosis , HIV Infections/drug therapy , HIV Infections/epidemiology , Health Knowledge, Attitudes, Practice , Humans , Male , Middle Aged , Mycobacterium tuberculosis/isolation & purification , Public Policy , Senegal/epidemiology , Treatment Outcome , Tuberculosis/diagnosis , Tuberculosis/epidemiology , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/epidemiology , Young Adult
2.
Article in English | MEDLINE | ID: mdl-33466374

ABSTRACT

Psychological distress imposed by the SARS-CoV-2 outbreak particularly affects patients with pre-existing medical conditions, and the progression of their diseases. Patients who fail to keep scheduled medical appointments experience a negative impact on care. The aim of this study is to investigate the psychosocial factors contributing to the cancellation of medical appointments during the pandemic by patients with pre-existing health conditions. Data were collected in eleven Italian hospitals during the last week of lockdown, and one month later. In order to assess the emotional impact of the SARS-CoV-2 outbreak and the subject's degree of psychological flexibility, we developed an ad hoc questionnaire (ImpACT), referring to the Acceptance and Commitment Therapy (ACT) model. The Impact of Event Scale-Revised (IES-R), the Depression, Anxiety and Stress Scale (DASS) and the Cognitive Fusion Questionnaire (CFQ) were also used. Pervasive dysfunctional use of experiential avoidance behaviours (used with the function to avoid thought, emotions, sensations), feelings of loneliness and high post-traumatic stress scores were found to correlate with the fear of COVID-19, increasing the likelihood of cancelling medical appointments. Responding promptly to the information and psychological needs of patients who cancel medical appointments can have positive effects in terms of psychological and physical health.


Subject(s)
Appointments and Schedules , COVID-19/psychology , Patients/psychology , Psychological Distress , Disease Outbreaks , Humans , Italy/epidemiology , Stress, Psychological/epidemiology , Surveys and Questionnaires
3.
Future Microbiol ; 15: 557-566, 2020 05.
Article in English | MEDLINE | ID: mdl-32476494

ABSTRACT

Clofazimine (CFZ), an old hydrophobic riminophenazine, has a wide range of antimycobacterial activity ranging from leprosy to nontuberculous mycobacterial diseases. CFZ has several advantages such as a favorable pharmacokinetic profile, dose-dependent side effects as well as low price. In this narrative review, we have assessed the clinical development of CFZ, starting from the potential in vitro mechanism of actions, to the spectrum of side effects and potential drug-drug interactions, highlighting its current place in therapy and future possible use in leprosy, nontuberculous mycobacterial diseases and drug-resistant tuberculosis.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Clofazimine/therapeutic use , Leprosy/drug therapy , Mycobacterium Infections, Nontuberculous/drug therapy , Animals , Anti-Bacterial Agents/adverse effects , Drug Resistance, Bacterial , Humans , Leprosy/microbiology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium leprae/drug effects , Mycobacterium tuberculosis/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...